Frances M. Daley

London, ENG UB83PH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

M-FISH evaluation of chromosome aberrations to examine for historical exposure to ionising radiation due to participation at British nuclear test sites.

M-FISH evaluation of chromosome aberrations to examine for historical exposure to ionising radiation due to participation at British nuclear test sites.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: October 17, 2023

Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.

Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.

Journal: EBioMedicine

Published: August 22, 2022

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.

Journal: Cancer research

Published: May 29, 2020

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Journal: Nature communications

Published: July 18, 2019

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 18, 2019

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Journal: The journal of pathology. Clinical research

Published: May 25, 2018

Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers.

Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers.

Journal: The journal of pathology. Clinical research

Published: February 13, 2018

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.

Journal: Breast cancer research and treatment

Published: January 05, 2018

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.

Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: December 18, 2017

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

Journal: International journal of cancer

Published: November 03, 2017

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.

Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer.

Journal: Molecular cancer therapeutics

Published: August 08, 2017

SOX11 promotes invasive growth and ductal carcinoma in situ progression.

SOX11 promotes invasive growth and ductal carcinoma in situ progression.

Journal: The Journal of pathology

Published: March 15, 2017

Showing 1-12 of 27

Last Updated: 09/26/2026